Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5813 posts found.

FDA approves Lipocine’s IND for adult epilepsy treatment

July 12, 2022 Manufacturing and Production

The FDA has accepted Lipocine’s Investigational New Drug Application (IND) for its neuroactive steroid (NAS) candidate, LPCN 2101, as a …
News

NIH grant for research into functional cure for HIV

July 12, 2022 Manufacturing and Production

The NIH has granted Oregon Health and Science Univerity (OHSU) a $5 million grant for the research of its one-time …
News

Vasopharm GmbH announces positive data from clinical trials in traumatic brain injury

July 12, 2022 Manufacturing and Production

Vasopharm GmbH has announced the results of significantly reduced brain microdialyse lactate levels in the Phase II (NOSTRA) and Phase …
News

Application to FDA for first-ever over-the-counter birth control pill

July 12, 2022 Manufacturing and Production

The FDA is due to consider whether oral birth control medication should be made available to consumers over the counter, …
News

Hospitals around UK reintroduce mandatory face masks amid COVID surge

July 5, 2022 Manufacturing and Production

Patients, visitors and staff are once again being told to wear face masks in hospitals across the UK, due to …
News

Mogrify and Astellas collaborate for research on treatments for sensorineural hearing loss

July 5, 2022 Manufacturing and Production

Mogrify and Astellas have announced a collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing …
News

New test aims to tackle prostate cancer rates in Black men

July 5, 2022 Manufacturing and Production

A new genetic blood test is being developed for Black men, using DNA information and AI technology, aiming to combat …
News

UK doctors warn of industrial action, call for pay rise

June 28, 2022 Manufacturing and Production

Members of the British Medical Association (BMA) have voted to press ministers to agree to a pay rise of up …
News

BASILEA announces positive results of Phase IIII study into SAB treatment

June 28, 2022 Manufacturing and Production

Basilea Pharmaceutica has announced positive topline results for the Phase III ERADICATE study, evaluating ceftobiprole in the treatment of adult …
News

EMA grants Bavarian Nordic’s respiratory treatment access to priority medicines scheme

June 28, 2022 Manufacturing and Production

The EMA has granted access to its priority medicines (PRIME) scheme for MVA-BN RSV in the active immunisation for the …
News

Positive CHMP opinion for biosimilar for cancer treatment

June 28, 2022 Manufacturing and Production

The CHMP of the EMA has adopted a positive opinion for the marketing authorisation of a bevacizumab biosimilar candidate, Vegzelma. …
News

First patient enrolled in melanoma study

May 24, 2022 Manufacturing and Production

Pierre Fabre and the European Organisation for Research and Treatment of Cancer (EORTC) have announced the screening of the first …
News

35 common health conditions GPs will no longer issue a prescription for

May 24, 2022 Manufacturing and Production

The NHS has published a list of 35 conditions that no longer require a prescription from a GP. These include …
News

131 confirmed cases of monkeypox reported in 19 countries

May 24, 2022 Manufacturing and Production

UK officials have warned that monkeypox could turn into a Europe-wide endemic if pets catch the virus. This could also …
News

Regeneron treatment fights ultra-rare form of high cholesterol in children

May 24, 2022 Manufacturing and Production

Regeneron has shared positive results from its Phase III trial of a candidate drug, for children with a rare, life-threatening …
News

Latest content

FDA approves AbbVie’s Skyrizi for UC treatment

June 20, 2024

Takeda shares data from phase 3 trial of CIPD treatment

June 20, 2024

EC grants marketing authorisation to Sobi’s Altuvoct for haemophilia A treatment

June 19, 2024

First patient dosed in Assembly Biosciences’ phase 1b trial for hepatitis B treatment

June 19, 2024

FDA approves Merck’s Capvaxive for prevention of pneumococcal disease

June 18, 2024